Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant women

被引:13
作者
Song, Ling [1 ]
Yu, Zhiheng [2 ]
Xu, Yifan [3 ]
Li, Xiaobei [1 ]
Liu, Xuanlin [3 ]
Liu, Dongyang [2 ]
Zhou, Tianyan [1 ]
机构
[1] Peking Univ, Beijing Key Lab Mol Pharmaceut & New Drug Deliver, Sch Pharmaceut Sci, Dept Pharmaceut, Beijing 100191, Peoples R China
[2] Peking Univ, Drug Clin Trial Ctr, Hosp 3, Beijing 100191, Peoples R China
[3] Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100191, Peoples R China
基金
比尔及梅琳达.盖茨基金会; 中国国家自然科学基金;
关键词
Chinese pregnant women; physiologically-based pharmacokinetic model; renally cleared drug; SERUM BACTERICIDAL ACTIVITIES; CLINICAL PHARMACOKINETICS; HEALTHY; CEFUROXIME; CEFTRIAXONE; CEFTAZIDIME; AZTREONAM; YOUNG; PHARMACODYNAMICS; FLUCONAZOLE;
D O I
10.1002/bdd.2243
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim The aim of this study was to build and verify a preliminary physiologically based pharmacokinetic (PBPK) model of Chinese pregnant women. The model was used to predict maternal pharmacokinetics (PK) of 6 predominantly renally cleared drugs. Method Based on SimCYP Caucasian pregnancy population dataset, the preliminary Chinese pregnant population was built by updating several key parameters and equations according to physiological parameters of Chinese (or Japanese) pregnant women. Drug-specific parameters of 6 renally cleared drugs were validated through PBPK modeling of Caucasian non-pregnant, Caucasian pregnant and Chinese non-pregnant population. The preliminary PBPK model of Chinese pregnant population was then developed by integrating the preliminary Chinese pregnant population and the drug-specific parameters. This model was verified by comparing the predicted maternal PK of these 6 drugs with the observed in vivo data from the literature. Results The preliminary Chinese pregnant population PBPK model successfully predicted the PK of 6 target drugs for different pregnancy stages. The predicted plasma concentrations time profiles fitted the observed data well, and most predicted PK parameters were within 2-fold of observed data.Conclusions: The preliminary Chinese pregnant population PBPK model provided a useful tool to predict the maternal PK of 6 predominantly renally cleared drugs in Chinese pregnant women.
引用
收藏
页码:248 / 267
页数:20
相关论文
共 83 条
[1]   Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal PregnancyA Database for Parameters Required in Physiologically Based Pharmacokinetic Modelling [J].
Khaled Abduljalil ;
Penny Furness ;
Trevor N. Johnson ;
Amin Rostami-Hodjegan ;
Hora Soltani .
Clinical Pharmacokinetics, 2012, 51 (6) :365-396
[2]   Amoxicillin pharmacokinetics in pregnant women: Modeling and simulations of dosage strategies [J].
Andrew, M. A. ;
Easterling, T. R. ;
Carr, D. B. ;
Shen, D. ;
Buchanan, M. L. ;
Rutherford, T. ;
Bennett, R. ;
Vicini, P. ;
Hebert, M. F. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (04) :547-556
[3]  
[Anonymous], 2015, OBSTET GYNECOL, V126, pe100
[4]  
[Anonymous], 2019, THESIS
[5]   COMPARATIVE PHARMACOKINETICS OF CEFTRIAXONE AFTER SUBCUTANEOUS AND INTRAVENOUS ADMINISTRATION [J].
BORNER, K ;
LODE, H ;
HAMPEL, B ;
PFEUFFER, M ;
KOEPPE, P .
CHEMOTHERAPY, 1985, 31 (04) :237-245
[6]   PHARMACOKINETICS AND PROTEIN-BINDING OF CEFTRIAXONE DURING PREGNANCY [J].
BOURGET, P ;
FERNANDEZ, H ;
QUINQUIS, V ;
DELOUIS, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (01) :54-59
[7]   CEFUROXIME - POTENTIAL USE IN PREGNANT-WOMEN AT TERM [J].
BOUSFIELD, P ;
BROWNING, AK ;
MULLINGER, BM ;
ELSTEIN, M .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1981, 88 (02) :146-149
[8]   Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion [J].
Burgess, DS ;
Summers, KK ;
Hardin, TC .
CLINICAL THERAPEUTICS, 1999, 21 (11) :1882-1889
[9]  
Cao Guoying E., 1992, CHINESE J NEW DRUGS, V1, P51
[10]   Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers [J].
Chiu, LM ;
Menhinick, AM ;
Johnson, PW ;
Amsden, GW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (06) :1075-1079